Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
69.27 USD | -2.93% | -8.19% | +10.30% |
05-22 | Vaxcyte Insider Sold Shares Worth $599,909, According to a Recent SEC Filing | MT |
05-14 | Transcript : Vaxcyte, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 09:20 AM |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
7.54B | - | - | - | - | - | |
116B | ||||||
106B | ||||||
23.89B | - | |||||
21.58B | - | |||||
18.96B |
- Stock Market
- Equities
- PCVX Stock
- Charts Vaxcyte, Inc.
- Sector Chart